53 related articles for article (PubMed ID: 6417104)
1. Bromoergocriptine and growth hormone (GH) dynamics in health and hypersomatotropism.
Sachdev Y
J Assoc Physicians India; 1983 Apr; 31(4):195-9. PubMed ID: 6417104
[No Abstract] [Full Text] [Related]
2. Effects of pirenzepine, bromocriptine and their association on basal and GHRH- and TRH-induced GH secretion in acromegaly.
Fiszlejder L; Penacini O; Ratz S; Storani M; Oneto A; Guitelman A
Horm Res; 1991; 36(1-2):47-51. PubMed ID: 1814801
[TBL] [Abstract][Full Text] [Related]
3. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
Felt V; Nedvídková J
Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
[No Abstract] [Full Text] [Related]
4. Dynamics of growth hormone secretion in untreated acromegaly.
Dash RJ; Rao NS; Sriprakash ML; Sialy R
J Assoc Physicians India; 1987 May; 35(5):341-3. PubMed ID: 3121582
[No Abstract] [Full Text] [Related]
5. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly.
Maeda K
Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578
[No Abstract] [Full Text] [Related]
6. [Dynamic evaluation of GH secretion in acromegaly as a criterion for the choice of treatment].
Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA
Clin Ter; 1977 Aug; 82(3):203-12. PubMed ID: 410583
[No Abstract] [Full Text] [Related]
7. [Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
Felt V; Nedvídková J; Krejcík L; Hainer V
Cas Lek Cesk; 1977 May; 116(19):591-4. PubMed ID: 406999
[No Abstract] [Full Text] [Related]
8. Abnormal control of growth hormone secretion by opiate systems in acromegalic patients: a study with naloxone and 2-Br-alpha-ergocryptine (CB 154).
Agnati LF; Benfenati F; Frank G; Capelli M; Bernardi P; Calza L
Med Biol; 1981 Feb; 59(1):58-63. PubMed ID: 7266088
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
Felt V; Nedvídková J
Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
[No Abstract] [Full Text] [Related]
10. [Secretion dynamics of GH in 43 patients with acromegaly].
Liuzzi A; Chiodini PG; Botalla L; Cattabeni A; Tosi M; Cremascoli G
Folia Endocrinol; 1972 Oct; 25(5):393-400. PubMed ID: 4679241
[No Abstract] [Full Text] [Related]
11. [Effects on growth hormone secretion of a new somatostatin analogue (SMS 201-995) and nonspecific releasing hormones in patients with acromegaly].
Candrina R
Medicina (Firenze); 1988; 8(2):180-1. PubMed ID: 3147351
[No Abstract] [Full Text] [Related]
12. GH secretory dynamics and responsiveness to SMS 201-995 treatment in acromegaly.
Kim SW; Kim SY; Yang IM; Kim JW; Kim YS; Kim KW; Choi YK
Korean J Intern Med; 1988 Jul; 3(2):110-6. PubMed ID: 3155299
[TBL] [Abstract][Full Text] [Related]
13. Effects of thyroliberin (TRH), bromocriptine and cyproheptadine on somatotropin secretion in acromegaly.
Pawlikowski M; Strejczek H; Owczarczyk I; Komorowski J
Mater Med Pol; 1980; 12(1-2):70-3. PubMed ID: 6799708
[No Abstract] [Full Text] [Related]
14. Effect of bromocriptine on phosphatemia in acromegaly.
Gennari C; Galli M; Vattimo A; Loré F; Nuti R; Picchi M; Bernini M
Boll Soc Ital Biol Sper; 1977 Jul; 53(14):1173-7. PubMed ID: 603666
[No Abstract] [Full Text] [Related]
15. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
Felt V; Nedvídková J
Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
[No Abstract] [Full Text] [Related]
16. [Attempt at suppressing the THR-stimulated plasma growth hormone increase with the use of L-dopa in a cromegaly].
Kasperlik-Zaluska A; Migdalska B; Wiśniewska-Woźniak T; Kaniewski M
Endokrynol Pol; 1977; 28(1):31-5. PubMed ID: 401736
[No Abstract] [Full Text] [Related]
17. [Use of thyroliberin and parlodel in acromegaly].
Pronin VS
Vestn Akad Med Nauk SSSR; 1981; (6):71-4. PubMed ID: 6794239
[No Abstract] [Full Text] [Related]
18. Effects of sumatriptan on growth hormone releasing hormone-stimulated growth hormone secretion in acromegaly.
Cuttica CM; Sessarego P; Ponzani P; Falivene MR; Valenti S; De Martini D; Giusti M
Recenti Prog Med; 1997 Jun; 88(6):264-8. PubMed ID: 9233053
[TBL] [Abstract][Full Text] [Related]
19. Effects of thyrotropin-releasing hormone and its metabolites, Cyclo(His-Pro) and TRH-OH, on growth hormone and prolactin synthesis in primary cultured pituitary cells of the common carp, Cyprinus carpio.
Kagabu Y; Mishiba T; Okino T; Yanagisawa T
Gen Comp Endocrinol; 1998 Sep; 111(3):395-403. PubMed ID: 9707485
[TBL] [Abstract][Full Text] [Related]
20. Cholinergic modulation of growth hormone, prolactin and thyroid stimulating hormone responses to thyrotropin-releasing hormone in normal aging.
Giusti M; Giovale M; Sessarego P; Carraro A; Pompei A; Giordano G
Recenti Prog Med; 1995 Sep; 86(9):341-4. PubMed ID: 7569294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
